Oxford BioMedica plc Company Profile (LON:OXB)

About Oxford BioMedica plc

Oxford BioMedica plc logoOxford BioMedica plc is a gene and cell therapy company. The Company is engaged in lentiviral vector and cell therapy research, development and production. The Company's segments include Partnering, and R&D. The Partnering segment provides lentiviral vector bioprocessing and process development services to partners. The R&D segment is engaged in the development of in-vivo and ex-vivo gene and cell therapy products, and the development of lentivirus-related platform technology. The Company provides a platform of technologies and capabilities with which it designs, develops and produces gene and cell-based medicines. The Company's product pipeline of OXB-102, OXB-201, OXB-202 and OXB-302 addresses neurodegenerative and ocular diseases, and a range of cancers. OXB-102 is indicated for Parkinson's disease. OXB-202 is indicated for Ocular (corneal graft rejection). OXB-302 is indicated for cancer disease. Its OXB-201 is indicated for wet age-related macular degeneration.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: OXB
  • CUSIP:
Key Metrics:
  • Previous Close: $0.05
  • 50 Day Moving Average: $4.11
  • 200 Day Moving Average: $3.84
  • 52-Week Range: £26,648,460 - GBX 2.98
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $107.13M
  • Outstanding Shares: 2,664,846,000
Additional Links:

Analyst Ratings

Consensus Ratings for Oxford BioMedica plc (LON:OXB) (?)
Ratings Breakdown: 1 Hold Rating, 1 Buy Rating
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: GBX 5.65

Analysts' Ratings History for Oxford BioMedica plc (LON:OXB)
Show:
DateFirmActionRatingPrice TargetDetails
1/5/2017Jefferies Group LLCReiterated RatingBuyGBX 8View Rating Details
12/5/2016N+1 SingerReiterated RatingHoldGBX 3.30View Rating Details
4/16/2015Roth CapitalReiterated RatingBuyGBX 18View Rating Details
(Data available from 2/26/2015 forward)

Earnings

Earnings History for Oxford BioMedica plc (LON:OXB)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Oxford BioMedica plc (LON:OXB)
Current Year EPS Consensus Estimate: $-0.53 EPS

Dividends

Dividend History for Oxford BioMedica plc (LON:OXB)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Oxford BioMedica plc (LON:OXB)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/24/2017Lorenzo TallarigoInsiderBuy67,165GBX 4£2,686.60
12/15/2016Lorenzo TallarigoInsiderBuy65,993GBX 4£2,639.72
11/25/2016Lorenzo TallarigoInsiderBuy75,417GBX 4£3,016.68
10/25/2016Lorenzo TallarigoInsiderBuy77,864GBX 3£2,335.92
9/26/2016Lorenzo TallarigoInsiderBuy79,988GBX 3£2,399.64
8/25/2016Tallarigo ,LorenzoInsiderBuy62,257GBX 4£2,490.28
7/25/2016Tallarigo ,LorenzoInsiderBuy63,351GBX 4£2,534.04
6/24/2016Tallarigo ,LorenzoInsiderBuy62,847GBX 4£2,513.88
5/13/2016Diggle ,MartinInsiderBuy42,072GBX 5£2,103.60
5/12/2016Diggle ,MartinInsiderBuy45,428GBX 5£2,271.40
5/5/2016Diggle ,MartinInsiderBuy12,500GBX 6£750
5/4/2016Diggle ,MartinInsiderBuy44,689GBX 6£2,681.34
5/3/2016Diggle ,MartinInsiderBuy317,382GBX 6£19,042.92
4/29/2016Nolan,PeterInsiderBuy359,925GBX 6£21,595.50
4/22/2016Tallarigo ,LorenzoInsiderBuy41,083GBX 6£2,464.98
3/24/2016Tallarigo ,LorenzoInsiderBuy41,550GBX 6£2,493
2/26/2016Diggle ,MartinInsiderBuy29,345GBX 7£2,054.15
2/25/2016Tallarigo ,LorenzoInsiderBuy36,370GBX 7£2,545.90
2/24/2016Diggle ,MartinInsiderBuy46,693GBX 6£2,801.58
7/1/2015Diggle ,MartinInsiderBuy284,439GBX 0.09£256
6/30/2015Diggle ,MartinInsiderBuy775,000GBX 0.09£697.50
6/19/2015Diggle ,MartinInsiderBuy225,000GBX 0.08£180
6/12/2015Martin DiggleInsiderBuy283,978GBX 9.01£25,586.42
6/11/2015Martin DiggleInsiderBuy416,022GBX 9£37,441.98
6/9/2015Daniel SolandInsiderBuy500,000GBX 9.45£47,250
5/21/2015Andrew HeathInsiderBuy100,000GBX 10.60£10,600
5/19/2015Tim WattsInsiderBuy194,174GBX 10.30£19,999.92
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Oxford BioMedica plc (LON:OXB)
DateHeadline
News IconWatching the Charts on Shares of Oxford BioMedica PLC (OXB.L) - Rives Journal (LON:OXB)
rivesjournal.com - February 24 at 8:12 PM
proactiveinvestors.co.uk logoOxford Biomedica lauds “encouraging” trial results from a Phase I/II cancer trial involving its TroVax immunotherapy ... - Proactive Investors UK (LON:OXB)
www.proactiveinvestors.co.uk - February 24 at 8:12 PM
iii.co.uk logoOXFORD BIOMEDICA (LON:OXB)
www.iii.co.uk - February 24 at 8:41 AM
4-traders.com logoOxford BioMedica : Director Dealings (LON:OXB)
www.4-traders.com - February 24 at 8:41 AM
proactiveinvestors.co.uk logoOxford Biomedica lauds “encouraging” trial results from a Phase I/II cancer trial involving its TroVax immunotherapy product (LON:OXB)
www.proactiveinvestors.co.uk - February 24 at 8:41 AM
trustnet.com logoOxford Biomedica PLC (OXB) (LON:OXB)
www.trustnet.com - February 24 at 8:41 AM
News IconInvestor Corner: Checking the Charts for Oxford BioMedica PLC (OXB.L) - Searcy News (LON:OXB)
searcysentinel.com - February 23 at 7:11 PM
News IconShares to Watch: Indicator Update on Oxford BioMedica PLC (OXB.L) - Searcy News (LON:OXB)
searcysentinel.com - February 17 at 8:10 AM
News IconCompany Watch: Checking the Numbers on Shares of Oxford BioMedica PLC (OXB.L) - Providence Standard (LON:OXB)
providencestandard.com - February 14 at 10:55 PM
News IconSignal Watch: Checking the Numbers for Oxford BioMedica PLC (OXB.L) - Rives Journal (LON:OXB)
rivesjournal.com - February 13 at 9:29 AM
News IconAverage Directional Index Review for Oxford BioMedica PLC (OXB.L) - The Standard (LON:OXB)
6milestandard.com - February 11 at 1:02 AM
News IconStock Levels in Review for Oxford BioMedica PLC (OXB.L) - Baldwin Journal (LON:OXB)
baldwinjournal.com - February 9 at 8:16 PM
News IconQuick Review on Trend Indicator Levels: Oxford BioMedica PLC (OXB.L) - Davidson Register (LON:OXB)
davidsonregister.com - February 9 at 1:05 AM
News IconAnalysts Consensus For Oxford Biomedica (LON:OXB) - NewsDen (LON:OXB)
newsden.net - February 8 at 1:13 AM
News IconTale of the Tape: Technical Recap for Oxford BioMedica PLC (OXB.L) - Springdale Times (LON:OXB)
springdaletimes.com - February 1 at 8:14 PM
News IconTrading Roundup: Checking Technicals for Oxford BioMedica PLC (OXB.L) - Springdale Times (LON:OXB)
springdaletimes.com - January 27 at 12:24 AM
lse.co.uk logoDirector Dealings / Market Share Purchase - London South East (registration) (blog) (LON:OXB)
www.lse.co.uk - January 25 at 5:56 AM
News IconOxford Biomedica (LON:OXB) Analyst Target Prices - UK Market News (LON:OXB)
www.ukmarketnews.co.uk - January 25 at 5:56 AM
4-traders.com logoOxford BioMedica : Director Dealings / Market Share Purchase (LON:OXB)
www.4-traders.com - January 24 at 7:52 PM
News IconEquity Focus: Indicator Check on Shares of Oxford BioMedica PLC (OXB.L) - Springdale Times (LON:OXB)
springdaletimes.com - January 18 at 8:42 AM
News IconMarket Rover: Looking at Levels on Shares of Oxford BioMedica PLC (OXB.L) - Springdale Times (LON:OXB)
springdaletimes.com - January 17 at 7:28 PM
News IconJefferies International Gives Oxford BioMedica PLC Price Target With Potential 92.77% Upside - UK Market News (LON:OXB)
www.ukmarketnews.co.uk - January 7 at 12:48 AM
News IconCompany Focus: Zooming in on Shares of Oxford BioMedica PLC (LSE:OXB) - The Business Journal (LON:OXB)
belmontbusinessjournal.com - December 20 at 1:29 PM
News IconStock Short Interest Filing: Oxford BioMedica plc (OXB) Is Yet to See Trading Action on Dec 16 - Herald KS (LON:OXB)
heraldks.com - December 16 at 7:52 PM
investing.com logoOxford Biomedica: Encouraging Ctl019 Data In Novartis Venture ... - Investing.com (LON:OXB)
www.investing.com - December 6 at 11:49 PM
lse.co.uk logoFindings Reported by Novartis on CTL-019 at ASH - London South East (registration) (blog) (LON:OXB)
www.lse.co.uk - December 5 at 7:03 PM
News IconOxford Biomedica (LON:OXB) New Price Targets - UK Market News (LON:OXB)
www.ukmarketnews.co.uk - December 1 at 6:58 PM
News IconWhat The Charts Are Saying About Oxford BioMedica PLC (LSE:OXB) - The Business Journal (LON:OXB)
belmontbusinessjournal.com - December 1 at 6:58 PM
trustnet.com logoStrategic Alliance with Orchard Therapeutics (LON:OXB)
www.trustnet.com - November 30 at 11:58 AM
einnews.com logoOrchard Therapeutics Announces Strategic Alliance with Oxford BioMedica - EIN News (press release) (LON:OXB)
www.einnews.com - November 29 at 2:14 PM
News IconKeeping Tabs on Levels for Oxford BioMedica PLC (LSE:OXB) - The Business Journal (LON:OXB)
belmontbusinessjournal.com - November 29 at 2:14 PM
News IconOxford BioMedica Plc OXB Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (LON:OXB)
www.bioportfolio.com - November 23 at 9:55 AM
News IconOutstanding Analyst Ratings For Oxford Biomedica (LON:OXB) - UK Market News (LON:OXB)
www.ukmarketnews.co.uk - November 19 at 6:47 PM
publicnow.com logoGrant of options (Replacement) (LON:OXB)
www.publicnow.com - November 8 at 6:25 PM
News IconChecking on Indicators for Oxford BioMedica PLC (OXB.L) - Wall Street Confidential (LON:OXB)
wsconfidential.com - October 24 at 12:10 PM
News IconTrading Spotlight on Shares of Oxford BioMedica PLC (OXB.L) - Yankee Analysts (LON:OXB)
yankeeanalysts.com - October 22 at 10:40 AM
ft.com logoPublication of RetinoStat® (OXB-201) Phase I study (LON:OXB)
announce.ft.com - October 10 at 11:25 AM
publicnow.com logoOxford BioMedica Announces Publication of Pioneering RetinoStat® (OXB-201) Phase I Study Data in the Journal, Human Gene Therapy (LON:OXB)
www.publicnow.com - October 10 at 11:25 AM
News IconRecent Broker Updates On Oxford Biomedica (LON:OXB) - NewsDen (LON:OXB)
newsden.net - October 4 at 11:25 AM
lse.co.uk logoResult of General Meeting and Directors Dealing - London South East (registration) (blog) (LON:OXB)
www.lse.co.uk - September 30 at 6:43 PM
4-traders.com logoOxford BioMedica : Result of General Meeting and Directors Dealing (LON:OXB)
www.4-traders.com - September 30 at 11:54 AM
publicnow.com logoOxford BioMedica Result of General Meeting and Directors Dealing (LON:OXB)
www.publicnow.com - September 29 at 11:49 AM
stockmarketwire.com logoDirector Deals - Oxford BioMedica PLC (OXB) (LON:OXB)
www.stockmarketwire.com - September 26 at 11:26 AM
News IconOxford Biomedica (LON:OXB) Analyst Target Changes - National Daily Press (LON:OXB)
www.nationaldailypress.com - September 16 at 10:10 AM
4-traders.com logoOxford BioMedica : Proposed fundraising of £10 million by way of a placing, subscription and related party transaction (LON:OXB)
www.4-traders.com - September 14 at 10:54 AM
iii.co.uk logoFTSE stable despite Shell slump - Interactive Investor (LON:OXB)
www.iii.co.uk - September 13 at 11:32 AM
money.aol.co.uk logoShould you buy this healthcare company after its 39% fall? - AOL Money UK (LON:OXB)
money.aol.co.uk - September 13 at 11:32 AM
publicnow.com logoProposed fundraising of £10 million by way of a placing, subscription and related party transaction (LON:OXB)
www.publicnow.com - September 13 at 11:32 AM
biz.yahoo.com logoHalf Year 2016 Oxford BioMedica PLC Earnings Release - Before Market Open (LON:OXB)
biz.yahoo.com - September 13 at 11:32 AM
uk.finance.yahoo.com logoShould you buy this healthcare company after its 39% fall? (LON:OXB)
uk.finance.yahoo.com - September 13 at 11:32 AM

Social

What is Oxford BioMedica plc's stock symbol?

Oxford BioMedica plc trades on the London Stock Exchange (LON) under the ticker symbol "OXB."

Where is Oxford BioMedica plc's stock going? Where will Oxford BioMedica plc's stock price be in 2017?

2 equities research analysts have issued twelve-month target prices for Oxford BioMedica plc's stock. Their predictions range from GBX 3.30 to GBX 8. On average, they anticipate Oxford BioMedica plc's share price to reach GBX 5.65 in the next year.

When will Oxford BioMedica plc announce their earnings?

Oxford BioMedica plc is scheduled to release their next quarterly earnings announcement on Wednesday, April, 26th 2017.

How do I buy Oxford BioMedica plc stock?

Shares of Oxford BioMedica plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

How much does a share of Oxford BioMedica plc stock cost?

One share of Oxford BioMedica plc stock can currently be purchased for approximately GBX 4.02.


Last Updated on 2/26/2017 by MarketBeat.com Staff